4.8 Article

FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors

Journal

EMBO JOURNAL
Volume 31, Issue 2, Pages 351-365

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2011.390

Keywords

haematopoiesis; lineage commitment; stem cells; transcription

Funding

  1. European Commission (EuroCSC STREP)
  2. Associazione Italiana per la Ricerca sul Cancro (AIRC)
  3. Swedish Research Council (HematoLinne)
  4. Medical Research Council
  5. MRC [G0900892, MC_UU_12009/5, G0801073, G0701761, G0501838] Funding Source: UKRI
  6. Medical Research Council [G0900892, G0700711B, G0701761] Funding Source: researchfish

Ask authors/readers for more resources

The transcription factors that control lineage specification of haematopoietic stem cells (HSCs) have been well described for the myeloid and lymphoid lineages, whereas transcriptional control of erythroid (E) and megakaryocytic (Mk) fate is less understood. We here use conditional removal of the GATA-1 and FOG-1 transcription factors to identify FOG-1 as required for the formation of all committed Mk- and E-lineage progenitors, whereas GATA-1 was observed to be specifically required for E-lineage commitment. FOG-1-deficient HSCs and preMegEs, the latter normally bipotent for the Mk and E lineages, underwent myeloid transcriptional reprogramming, and formed myeloid, but not erythroid and megakaryocytic cells in vitro. These results identify FOG-1 and GATA-1 as required for formation of bipotent Mk/E progenitors and their E-lineage commitment, respectively, and show that FOG-1 mediates transcriptional Mk/E programming of HSCs as well as their subsequent Mk/E-lineage commitment. Finally, C/EBPs and FOG-1 exhibited transcriptional cross-regulation in early myelo-erythroid progenitors making their functional antagonism a potential mechanism for separation of the myeloid and Mk/E lineages. The EMBO Journal (2012) 31, 351-365. doi:10.1038/emboj.2011.390; Published online 8 November 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available